MitoRx Case Study: Promoting a published paper

“Scius’ communications expertise has been invaluable in promoting our groundbreaking R&D on small molecule mitochondrial modulators. The visibility we achieved, with Scius working closely with the comms teams at two Universities, has helped us build momentum and reinforce our position as a leader in mitochondrial-targeted obesity therapeutics.”

Dr. Jon Rees
CEO of MitoRx

Objectives

Promote preclinical R&D findings on a small molecule mitochondrial modulator, demonstrating promising efficacy in obesity reduction. Research published in the journal Pharmacological Research, in collaboration with scientists from Poland’s Jagiellonian University Medical College and the UK’s University of Exeter.
Support MitoRx’s positioning as an innovator in mitochondrial-targeted therapies for obesity and metabolic diseases.

Strategy

Developed a press release highlighting a new therapeutic pathway for alleviating obesity.
Co-ordinated with the University of Exeter’s press team on a ‘lay’ press release that distilled the research into accessible language for broader audiences.
Secured final approvals and coordinated timing with the press offices of the two collaborating universities.

Results

High engagement in international biotech trade media.
By pitching under embargo, secured an in-depth interview, resulting in placement in a major longevity-focused outlet, enhancing MitoRx’s visibility within the longevity space.
Successful coordination with prestigious academic institutions, showcasing the strength of MitoRx’s collaborations.